Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Moderate-intensity statin with ezetimibe vs. high-intensity statin in patients with diabetes and atherosclerotic cardiovascular disease in the RACING trial.
Lee YJ, Cho JY, You SC, Lee YH, Yun KH, Cho YH, Shin WY, Im SW, Kang WC, Park Y, Lee SY, Lee SJ, Hong SJ, Ahn CM, Kim BK, Ko YG, Choi D, Hong MK, Jang Y, Kim JS. Lee YJ, et al. Among authors: im sw. Eur Heart J. 2023 Mar 14;44(11):972-983. doi: 10.1093/eurheartj/ehac709. Eur Heart J. 2023. PMID: 36529993 Clinical Trial.
Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy in Patients at Very High Risk of Atherosclerotic Cardiovascular Disease: A Post Hoc Analysis From the RACING Randomized Clinical Trial.
Lee SJ, Cha JJ, Choi WG, Lee WS, Jeong JO, Choi S, Cho YH, Park W, Yoon CH, Lee YJ, Hong SJ, Ahn CM, Kim BK, Ko YG, Choi D, Hong MK, Jang Y, Hong SJ, Kim JS; RACING Investigators. Lee SJ, et al. JAMA Cardiol. 2023 Sep 1;8(9):853-858. doi: 10.1001/jamacardio.2023.2222. JAMA Cardiol. 2023. PMID: 37531130 Clinical Trial.
Comparison of the Efficacy and Safety of Fixed-dose S-Amlodipine/Telmisartan and Telmisartan in Hypertensive Patients Inadequately Controlled with Telmisartan: A Randomized, Double-blind, Multicenter Study.
Park CG, Ahn TH, Cho EJ, Kim W, Kim HS, Yang JY, Ryu JG, Kim CH, Hyeon MS, Tak SJ, Im SJ, Ha JW, Pyeon WB, Jae JG, Han GR, Doh JH, Im SW, Lee MM. Park CG, et al. Among authors: im sw, im sj. Clin Ther. 2016 Oct;38(10):2185-2194. doi: 10.1016/j.clinthera.2016.09.006. Epub 2016 Oct 6. Clin Ther. 2016. PMID: 27720505 Clinical Trial.
Iridium-Cooperated, Symmetry-Broken Manganese Oxide Nanocatalyst for Water Oxidation.
Park S, Jang T, Choi S, Lee YH, Cho KH, Lee MY, Seo H, Lim HK, Kim Y, Ryu J, Im SW, Kim MG, Park JS, Kim M, Jin K, Kim SH, Park GS, Kim H, Nam KT. Park S, et al. Among authors: im sw. J Am Chem Soc. 2023 Dec 13;145(49):26632-26644. doi: 10.1021/jacs.3c07411. Epub 2023 Dec 4. J Am Chem Soc. 2023. PMID: 38047734
Low-dose gemcitabine plus nab-paclitaxel versus standard-dose gemcitabine plus nab-paclitaxel in elderly patients with metastatic pancreatic cancer: A randomized Phase II trial.
Kamata K, Imai H, Matsumoto H, Yamashita Y, Kato T, Nishi K, Omoto S, Minaga K, Yamao K, Hyodo T, Im SW, Hara A, Yoshikawa T, Ishikawa R, Okamoto A, Yamazaki T, Nakai A, Ueshima K, Chiba Y, Takenaka M, Watanabe T, Kitano M, Kudo M. Kamata K, et al. Among authors: im sw. JGH Open. 2023 Sep 7;7(9):659-666. doi: 10.1002/jgh3.12966. eCollection 2023 Sep. JGH Open. 2023. PMID: 37744711 Free PMC article.
A whole-genome reference panel of 14,393 individuals for East Asian populations accelerates discovery of rare functional variants.
Choi J, Kim S, Kim J, Son HY, Yoo SK, Kim CU, Park YJ, Moon S, Cha B, Jeon MC, Park K, Yun JM, Cho B, Kim N, Kim C, Kwon NJ, Park YJ, Matsuda F, Momozawa Y, Kubo M; Biobank Japan Project; Kim HJ, Park JH, Seo JS, Kim JI, Im SW. Choi J, et al. Among authors: im sw. Sci Adv. 2023 Aug 9;9(32):eadg6319. doi: 10.1126/sciadv.adg6319. Epub 2023 Aug 9. Sci Adv. 2023. PMID: 37556544 Free PMC article.
76 results